Related Experiment Video

Updated: Jul 15, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

[Impact of specific antituberculosis therapy on gastrointestinal tract in children]

V L Paĭkov, O I Korol', L I Kravchenko

    Problemy Tuberkuleza
    |June 5, 1998
    PubMed

    Insights

    Antituberculosis agents did not affect the gastrointestinal tract in children with normal acid and pepsin production. Enveloping agents may help reduce side effects from tuberculostatic therapy.

    Area of Science:

    • Pediatrics
    • Gastroenterology
    • Infectious Diseases

    Background:

    • Tuberculosis treatment in children requires careful consideration of potential gastrointestinal side effects.
    • The impact of antituberculosis agents on gastric function in pediatric patients is not fully understood.

    Purpose of the Study:

    • To evaluate the effect of antituberculosis agents on the gastrointestinal tract in children.
    • To assess the influence of these agents on gastric acid and pepsin production.
    • To determine the necessity of adjunctive therapies for mitigating side effects.

    Main Methods:

    • Study involved 48 children aged 3-14 years undergoing treatment for tuberculous abnormalities.
    • Gastric acid and pepsin production were monitored during antituberculosis therapy.
    • Aggressive properties of gastric juice were assessed after 6 months of treatment.

    Main Results:

    • Antituberculosis agents showed no noticeable effect on the gastrointestinal tract in children with normal acid and pepsin levels.
    • Six months of treatment with effective antituberculosis agents did not alter the aggressive properties of gastric juice.
    • No significant impact on gastric function was observed.

    Conclusions:

    • Standard antituberculosis therapy appears safe for the pediatric gastrointestinal tract concerning acid and pepsin production.
    • The use of enveloping and mucus-forming agents is recommended to manage potential side effects of tuberculostatic therapy.
    • Further research may explore specific gastrointestinal protective strategies during pediatric tuberculosis treatment.

    More Related Videos

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    Related Concept Videos

    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Tuberculosis01:23

    Tuberculosis

    Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...